Katelijne De Wilde

PhD Thesis
open access

Novel myeloid regulators of rheumatic diseases

(2017)

A20 inhibition of STAT1 expression in myeloid cells : a novel endogenous regulatory mechanism preventing development of enthesitis

Katelijne De Wilde, Arne Martens, Stijn Lambrecht (UGent) , Peggy Jacques (UGent) , Michael Drennan (UGent) , Karlijn Debusschere (UGent) , Srinath Govindarajan (UGent) , Julie Coudenys (UGent) , Eveline Verheugen (UGent) , Fien Windels (UGent) , et al.

(2017) ANNALS OF THE RHEUMATIC DISEASES. 76(3). p.585-592

Add to list

Assessment of sensitivity to change of the European Scleroderma Study Group activity index

Karin Melsens, Filip De Keyser (UGent) , Saskia Decuman (UGent) , Guy Brusselle (UGent) , Michel De Pauw (UGent) , Ellen Deschepper (UGent) , Katelijne De Wilde, Dirk Elewaut (UGent) , YVES PIETTE (UGent) , Els Vandecasteele (UGent) , et al.

(2016) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 34(5, suppl. 100). p.148-151

Add to list

Tofacitinib inhibits inflammation and new bone formation in murine spondyloarthritis but does not adversely inhibit normal human MSC function

Rik Lories, Katelijne De Wilde, Kerri Heritage, Richard Cuthbert, Elena Jones, Karlijn Debusschere (UGent) , Dennis McGonagle and Dirk Elewaut (UGent)

(2015) ARTHRITIS & RHEUMATOLOGY. 67(suppl. 10).

Add to list

Integrating the pathogenesis of spondyloarthritis: gut and joint united?

Katelijne De Wilde, Karlijn Debusschere (UGent) , Sam Beeckman, Peggy Jacques (UGent) and Dirk Elewaut (UGent)

(2015) CURRENT OPINION IN RHEUMATOLOGY. 27(2). p.189-196

Add to list

The thymic microenvironment differentially regulates development and trafficking of invariant NKT cell sublineages

Michael Drennan (UGent) , Srinath Govindarajan (UGent) , Katelijne De Wilde, Susan M Schlenner, Carl Ware, Sergei Nedospasov, Hans-Reimer Rodewald and Dirk Elewaut (UGent)

(2014) JOURNAL OF IMMUNOLOGY. 193(12). p.5960-5972

Add to list

Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development

Stijn Lambrecht (UGent) , Vanessa Smith (UGent) , Katelijne De Wilde, Julie Coudenys (UGent) , Saskia Decuman (UGent) , Dieter Deforce (UGent) , Filip De Keyser (UGent) and Dirk Elewaut (UGent)

(2014) ARTHRITIS & RHEUMATOLOGY. 66(2). p.418-427

Academic Bibliography

Katelijne De Wilde

Novel myeloid regulators of rheumatic diseases

A20 inhibition of STAT1 expression in myeloid cells : a novel endogenous regulatory mechanism preventing development of enthesitis

Assessment of sensitivity to change of the European Scleroderma Study Group activity index

Tofacitinib inhibits inflammation and new bone formation in murine spondyloarthritis but does not adversely inhibit normal human MSC function

Integrating the pathogenesis of spondyloarthritis: gut and joint united?

The thymic microenvironment differentially regulates development and trafficking of invariant NKT cell sublineages

Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development

Contents

Support

Contact